Department of Histopathology, St James's Hospital, Dublin, Ireland.
Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland.
Ir J Med Sci. 2021 May;190(2):505-514. doi: 10.1007/s11845-020-02330-3. Epub 2020 Jul 29.
Irish Health Research Regulations (HRRs) were introduced following the European Union (EU) General Data Protection Regulation (GDPR) in 2018. The HRRs described specific supplementary regulatory requirements for research regarding governance, processes and procedure that impact on several facets of research. The numerous problems that the HRRs and particularly "explicit consent" inadvertently created were presented under the auspices of the Irish Academy of Medical Sciences (IAMS) on November 25, 2019, at the Royal College of Surgeons in Ireland.
The objective of this review was to obtain feedback and to examine the impact of GDPR and the HRRs on health research in Ireland in order to determine whether the preliminary feedback, presented at the IAMS meetings, was reflected at a national level.
Individuals from the research community were invited to provide feedback on the impact, if any, of the HRRs on health research. Retrospective patient recruitment and consent outside a hospital setting for a multi-institutional Breast Predict study (funded by the Irish Cancer Society) were also analysed.
Feedback replicated the issues presented at the IAMS with additional concerns identified. Only 20% of the original target population (n = 1987) could be included in the Breast Predict study.
Our results confirm that the HRRs have had a significantly negative impact on health research in Ireland. Urgent meaningful engagement between patient advocate groups, the research community and legislators would help ameliorate these impacts.
爱尔兰健康研究法规(HRRs)于 2018 年欧盟(EU)通用数据保护条例(GDPR)出台后引入。HRRs 描述了针对治理、流程和程序的研究的具体补充监管要求,这些要求影响了研究的几个方面。2019 年 11 月 25 日,在爱尔兰皇家外科医学院(RCSI),爱尔兰医学科学院(IAMS)以“明确同意”为幌子提出了 HRRs 尤其是“明确同意”造成的诸多问题。
本研究旨在获得反馈,并检查 GDPR 和 HRRs 对爱尔兰健康研究的影响,以确定在 IAMS 会议上提出的初步反馈是否反映在国家层面上。
邀请研究界的个人对 HRRs 对健康研究的影响(如果有的话)提供反馈。还分析了在医院环境之外进行回顾性患者招募和同意的情况,这是一项由爱尔兰癌症协会资助的多机构乳房预测研究(Breast Predict study)。
反馈复制了 IAMS 会议上提出的问题,并确定了其他问题。乳房预测研究只能纳入原始目标人群的 20%(n=1987)。
我们的结果证实,HRRs 对爱尔兰的健康研究产生了重大的负面影响。患者权益团体、研究界和立法者之间进行紧急、有意义的互动,将有助于缓解这些影响。